As high heregulin expression was detected in a subpopulation of HNSCC tumors, the correlation between heregulin expression and the clinical outcome of patients with HNSCC treated with cetuximab merits further investigation. The gene discussed is NRG1; the disease is head and neck squamous cell carcinoma.